copenlu/druid huggingface dataset:
Claim: “We know mask mandates work. There’s enough evidence out there between counties that have done it and counties that haven’t." (Gordon Hintz, 2021-02-06)
Evidence (2022-03-01): Parimal will correct me if I'm wrong, but I believe it was last June I signed an executive order that, indeed, explicitly allowed individual communities to take steps, as you are seeing in communities around the state, because we had a lot of folks legitimately asking us for that ability. Early on in the pandemic, we were worried about unintended consequences. That's when we knew little. In other words, if restaurants were open on one side of the Hudson versus the other or in Essex County but not in Hudson County, or you had mandate here and not there, would you have a tilt and have unintended consequences and capacity issues, etc.? I just – that's just something we're just not as concerned about. Folks understand overwhelmingly the need to wear a mask. They understand that it's not going to be the trigger in most cases whether I go to Restaurant A or Restaurant B or Hospital A or Hospital B. That's the way we have wanted it. The fact that you're seeing these mandates being put in place is something we had anticipated.
Claim: “We know mask mandates work. There’s enough evidence out there between counties that have done it and counties that haven’t." (Gordon Hintz, 2021-02-06)
Evidence (2020-05-13): Evidence of the benefits of mandatory masks is now overwhelming. Our hospital system would not be able to stop viral spread without them. But will supplies keep up? Factories are increasing production of both surgical masks and N95s as rapidly as possible, but they don’t come close to meeting health-care workers’ needs, let alone supplying the general public, and they won’t for months to come. It should therefore be no surprise that foreign factories have prioritized meeting their own countries’ needs, often under government edict, and the world is fighting over what’s left. [...] But it was not enough. An outbreak occurred in a housing unit for disabled residents. Four of the eight residents there became infected, possibly by a staff member who subsequently tested positive for COVID-19. All four died. The week that my health system mandated masks, Lasell Village began requiring its staff to wear them, too, although because of a shortage of surgical masks, most employees got only one per week, plus a backup cloth mask. A few days later, residents and local nonprofits had sewed enough cloth masks to distribute one to every resident as well.
Claim: “We know mask mandates work. There’s enough evidence out there between counties that have done it and counties that haven’t." (Gordon Hintz, 2021-02-06)
Evidence (2020-07-13): We had the worst spike per capita on the globe and we brought it down. Now you see these other states are going higher than New York. Those masks work. We were the first state to start mandatory masks April 15. All the science now says for sure masks make a big difference. One of the models last week, the IHME model, the Gates funded model that the White House uses, actually projected 40,000 more Americans will die if we don’t have a national mask policy. It’s clear. [...] We want masks and PPE whenever students or staff cannot maintain social distancing. Masks work. They work for children, they work for teachers, they work for everyone. We have social distancing, six feet separations. We have cohort structures in the guidelines. Guidelines on transportation, food service, after care, extracurricular activity. Every child and person entering will be screened. Tracing has to work in the schools, cleaning and closure procedures. That’s all in the guidelines, and again we’ve done the health guidelines. The State Department of Education, which I do not run separate agency, they’ll do the education guidelines incorporating ours. Well then, what’s the bad news? All our numbers are good. All our numbers are good.
Claim: “We know mask mandates work. There’s enough evidence out there between counties that have done it and counties that haven’t." (Gordon Hintz, 2021-02-06)
Evidence (2021-07-29): We need to wear masks to protect each other and to stop the rapid spread of this virus as we work to get more people vaccinated. And I hope all Americans who live in areas with substantial or high case rates will follow the mask guidance that’s being laid down by the CDC. I certainly will. And I have — because this is one of those areas, in Washington. [...] Additionally, the CDC has provided clear guidance on how all schools can safely protect the kids and bring them back to the classroom: every student wear a mask. It’s that simple.
Claim: “We know mask mandates work. There’s enough evidence out there between counties that have done it and counties that haven’t." (Gordon Hintz, 2021-02-06)
Evidence (2020-05-01): The announcement this week of the Santa Clara County Health Officer’s extension of the Shelter-in-Place order through the end of May includes a mandate for transit personnel and passengers to wear face coverings while riding beginning Monday, May 4. That means anyone boarding VTA vehicles will have to comply by donning a face covering and continue to adhere to social distancing requirements to the greatest extent feasible. Bus and light rail operators will also be wearing face coverings while in their vehicles. VTA is getting the word out through posters, recorded messaging onboard vehicles and platforms, and other public messaging to remind passengers about this new requirement. In some municipalities, such as Cupertino, face covering orders have already been issued so the new County order will bring consistency to all locations served by VTA.
Claim: “We know mask mandates work. There’s enough evidence out there between counties that have done it and counties that haven’t." (Gordon Hintz, 2021-02-06)
Evidence (2021-04-19): These now — these data are now available on the CDC website at CDC.gov, with information on how healthcare providers and public health authorities can report breakthrough infections if they see them occur. We will update the data as it is reported to the CDC. [...] And sort of a general sense of when we can expect to see — one of the — you know, we’ve seen in Israel, they’ve begun to lift their outdoor mask mandates at a 60-some-odd percent vaccination rate. Is that a similar milestone that you’re looking for when you change that — that recommendation here in the U.S.? And any other sort of, you know — what milestones should the public expect, as more people get vaccinated, for when they can get back to normal?
Claim: “We know mask mandates work. There’s enough evidence out there between counties that have done it and counties that haven’t." (Gordon Hintz, 2021-02-06)
Evidence (2022-02-07): The masking policy I just don't think is particularly effective anyway but there’s no reason that you can’t bring it back. So say, worst case scenario after Omicron, there's another variant that's even more infectious, but is more deadly. You know, it wouldn't be a bad idea for our public health agencies to really put some money into studies about different kinds of masks, KN-95, etc. to see exactly the impact they have, and how effective of a tool are they. Because we know of the downsides, but it is really important as we layer on risk mitigation, and then pull it back, that we that we have a quantitative guess at least as to the amount of impact that's going to have. More than two years into this, we really don't know that number. We just don't have robust data to tell us that our mask mandates really do much. We looked at a couple of different school districts and counties in Florida and Tennessee, in North Dakota, looking at schools that have mask mandates and those that don't with similar vaccination rates. There's no difference in the school transmission.
Claim: “We know mask mandates work. There’s enough evidence out there between counties that have done it and counties that haven’t." (Gordon Hintz, 2021-02-06)
Evidence (2023-02-10): I do want to remind people there are still places we should mask up, like the doctor’s office or on public transportation.
Claim: The American Medical Association rescinded a previous statement and now says "hydroxychloroquine is okay" for COVID-19. (Rush Limbaugh, 2020-12-15)
Evidence (2020-12-15): The American Medical Association never took back its March statement concerning hydroxychloroquine. The group tweeted that Rush Limbaugh’s claim is wrong. The AMA considered a resolution to rescind a previous statement on the drug when the group’s policymaking body met in November. But it ultimately rejected the resolution. The website Limbaugh cited has corrected its story.
Claim: The American Medical Association rescinded a previous statement and now says "hydroxychloroquine is okay" for COVID-19. (Rush Limbaugh, 2020-12-15)
Evidence (2020-12-15): No, the AMA didn’t rescind statement on hydroxychloroquine [...] Conservative radio host Rush Limbaugh falsely claimed that the American Medical Association rescinded a previous statement and came out in support of hydroxychloroquine, the drug pushed by President Donald Trump for months as a potential treatment for COVID-19. [...] The Published Reporter, "UPDATE: American Medical Association Considers Resolution On Statement Against Prescription Of Hydroxychloroquine For COVID-19 Patients," (archived original), Dec. 11, 2020
Claim: The American Medical Association rescinded a previous statement and now says "hydroxychloroquine is okay" for COVID-19. (Rush Limbaugh, 2020-12-15)
Evidence (2020-05-22): RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis [...] RETRACTED: Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous? [...] Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
Claim: The American Medical Association rescinded a previous statement and now says "hydroxychloroquine is okay" for COVID-19. (Rush Limbaugh, 2020-12-15)
Evidence (2021-04-01): Data on the efficacy of hydroxychloroquine or lopinavir-ritonavir for the treatment of high-risk outpatients with COVID-19 in developing countries are needed. [...] Given the DSMB decision, based on the Brazilian data confirming a lack of clinical benefits for hydroxychloroquine and lopinavir-ritonavir for outpatient treatment of patients with COVID-19, the enrollment in the United States and South Africa for these interventions has been discontinued. Other agents are rapidly being screened and developed for SARS-CoV-2 infection and can be incorporated into this master protocol for an outpatient platform trial as additional groups. The flexible platform trial design allows additional agents to be added and tested with standardized eligibility criteria, outcomes, and measurements. If an intervention is shown to be effective, this design allows the replacement of the placebo group with the effective intervention as the comparator. [...] M, et al; BCN PEP-CoV-2 RESEARCH GROUP. Hydroxychloroquine for early treatment of adults with mild Covid-19: a randomized-controlled trial.
Claim: The American Medical Association rescinded a previous statement and now says "hydroxychloroquine is okay" for COVID-19. (Rush Limbaugh, 2020-12-15)
Evidence (2024-10-06): - FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems. US Food and Drug Administration (FDA). Accessed Feb 2, 2021 at https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or - Assessment of Evidence for COVID-19-Related Treatments: Updated 01/29/2021. ASHP. Accessed Feb. 2, 2021 at https://www.ashp.org/-/media/assets/pharmacy-practice/resource-centers/Coronavirus/docs/ASHP-COVID-19-Evidence-Table.ashx - NIH halts clinical trial of hydroxychloroquine. Study shows treatment does no harm, but provides no benefit. US National Institutes of Health. Accessed August 13, 2020 at https://www.nih.gov/news-events/news-releases/nih-halts-clinical-trial-hydroxychloroquine - Solidarity Clinical Trials for COVID-19 Treatments. WHO. Accessed Feb. 2, 2021 at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments - Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine. US Food and Drug Administration. Accessed August 12, 2020 at https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and - The RECOVERY Trial. No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19. Accessed August 12, 2020 at https://www.recoverytrial.net/files/hcq-recovery-statement-050620-final-002.pdf - Hornby P, Mafham M, Linsel L, et al Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial. medRxiv 2020.07.15.20151852; doi: https://doi.org/10.1101/2020.07.15.20151852 - Kim A, Gandhi R, Hirsh M, et al. Coronavirus disease 2019 (COVID-19): Management in hospitalized adults. Up to Date.
Claim: The American Medical Association rescinded a previous statement and now says "hydroxychloroquine is okay" for COVID-19. (Rush Limbaugh, 2020-12-15)
Evidence (2021-10-02): Prescribing clinicians and eye care specialists share responsibility for safely prescribing hydroxychloroquine (HCQ) and screening for the potential risk of retinopathy. Two relevant national societies, the American College of Rheumatology (ACR) and the American Academy of Ophthalmology (AAO), have independently offered management guidelines (1, 2), but this is the first joint statement to emphasize points of agreement that should be recognized by practitioners in all specialties. The ACR and AAO are joined in this statement with the American Academy of Dermatology (AAD) and Rheumatologic Dermatology Society (RDS) [...] This consensus opinion is limited by the relative dearth of data on dosage of hydroxychloroquine required to achieve clinical benefit, the lack of prospective data on toxicity, the need for additional studies on the value of blood levels in achieving efficacy or avoiding toxicity, and the need for pharmacogenomic studies that might identify those at greater (or lesser) risk.
Claim: The American Medical Association rescinded a previous statement and now says "hydroxychloroquine is okay" for COVID-19. (Rush Limbaugh, 2020-12-15)
Evidence (2020-12-17): Here's why: Conservative radio host Rush Limbaugh falsely claimed that the American Medical Association rescinded a previous statement and came out in support of hydroxychloroquine, the drug pushed by President Donald Trump for months as a potential treatment for COVID-19. [...] "In March, AMA urged caution about prescribing hydroxychloroquine off-label to treat #COVID19," the AMA wrote, with a link to Poynter’s Covering COVID-19 newsletter by Al Tompkins. "Our position remains unchanged. Evidence-based #science & practice must guide these determinations." [...] The Published Reporter, "UPDATE: American Medical Association Considers Resolution On Statement Against Prescription Of Hydroxychloroquine For COVID-19 Patients," (archived original), Dec. 11, 2020
Claim: The American Medical Association rescinded a previous statement and now says "hydroxychloroquine is okay" for COVID-19. (Rush Limbaugh, 2020-12-15)
Evidence (2020-06-23): The American Medical Association, American Pharmacists Association, and American Society of Health-System Pharmacists appreciates the Food and Drug Administration’s (FDA’s) continuing efforts to review and advise the nation on the safe and effective use of hydroxychloroquine, chloroquine, and other medications to prevent and treat coronavirus. We recognize the body of evidence for addressing the COVID-19 global pandemic is evolving rapidly, requiring vigilant yet timely decision making. We emphasize that the FDA’s recent announcement to cancel the emergency use authorizations for hydroxychloroquine and chloroquine for certain hospitalized patients with COVID-19 does not apply to other evidence-based uses of these medications for conditions such as rheumatoid arthritis and lupus. Our organizations continue to advocate for medication-use policies that ensure patients who need hydroxychloroquine and chloroquine do not face unintended barriers to evidence-based care. We encourage patients and healthcare providers to consult the FDA’s Frequently Asked Questions on the Revocation of the EUA for Hydroxychloroquine and Chloroquine Phosphate, and COVID-19 related information and resources available from our three organizations.
Claim: The American Medical Association rescinded a previous statement and now says "hydroxychloroquine is okay" for COVID-19. (Rush Limbaugh, 2020-12-15)
Evidence (2023-09-01): Self-reported use of ivermectin or hydroxychloroquine, endorsing false statements related to COVID-19 vaccination, self-reported trust in various institutions, conspiratorial thinking measured by the American Conspiracy Thinking Scale, and news sources. [...] The antiparasitic agents ivermectin and hydroxychloroquine were both touted as cures for the SARS-CoV-2 virus, in the absence of evidence of efficacy. Despite multiple US Food and Drug Administration (FDA) statements clarifying that these medicines are not indicated for COVID-19,1 prescribing increased substantially in the US, Canada, and Australia in the first year of the pandemic2-4; 1 study3 showed an association between prescribing and county-level support for Donald Trump. Beyond a lack of efficacy, such prescriptions were associated with risk of toxic effects.5 Their use thus introduced inefficiencies and expense as well as potential adverse effects on health and may help explain the observed association between more misinformation-prone counties and greater COVID-19 death rates.6 [...] PA. Hydroxychloroquine for COVID-19: variation in regional political preferences predicted new prescriptions after President Trump’s endorsement.
Claim: The American Medical Association rescinded a previous statement and now says "hydroxychloroquine is okay" for COVID-19. (Rush Limbaugh, 2020-12-15)
Evidence (2022-01-21): Randomized controlled trials — the highest standard of evidence — have found that hydroxychloroquine isn’t beneficial in treating hospitalized COVID-19 patients. Yet social media posts are claiming the drug works, and conservative outlets have touted an unpublished, and much-criticized, observational study as evidence of the drug’s effectiveness. [...] Boulware, David R. et. al. "A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19." New England Journal of Medicine. 383.6 (2020). [...] Cavalcanti, Alexandre B. et. al. "Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19." New England Journal of Medicine. 383.21 (2020).
Claim: The American Medical Association rescinded a previous statement and now says "hydroxychloroquine is okay" for COVID-19. (Rush Limbaugh, 2020-12-15)
Evidence (2020-04-17): We are issuing this joint statement to highlight the important role that physicians, pharmacists and health systems play in being just stewards of health care resources during times of emergency and national disaster. We are aware that some physicians and others are prescribing or dispensing medications currently identified as potential treatments or prophylaxis for COVID-19 (e.g., chloroquine or hydroxychloroquine, azithromycin) for themselves, their families, or their colleagues. In addition, some entities have been purchasing excessive amounts of these medications through commercial distribution channels in anticipation of potentially using them for COVID-19 prevention and treatment. We strongly oppose these actions that can lead to supply disruptions for patients who need these medicines for chronic conditions. [...] We are further concerned by the confusion that may result from various state government agencies and boards issuing emergency rules limiting or restricting access to chloroquine, hydroxychloroquine or other emerging therapies or requiring new procedures for physicians and other healthcare professionals and patients. If these bodies promulgate new rules, we urge that they emphasize professional responsibility and leave room for professional judgment. We further urge that patients already on these medications for chronic conditions should not be negatively impacted by new laws, rules or other guidance. In a time of national pandemic, now is not the time for states to issue conflicting guidance, however well-intentioned, that could lead to unintended consequences.
Claim: The American Medical Association rescinded a previous statement and now says "hydroxychloroquine is okay" for COVID-19. (Rush Limbaugh, 2020-12-15)
Evidence (2020-01-07): June 15, 2020 Update: Based on ongoing analysis and emerging scientific data, FDA has revoked the emergency use authorization (EUA) to use hydroxychloroquine and chloroquine to treat COVID-19 in certain hospitalized patients when a clinical trial is unavailable or participation is not feasible. We made this determination based on recent results from a large, randomized clinical trial in hospitalized patients that found these medicines showed no benefit for decreasing the likelihood of death or speeding recovery. This outcome was consistent with other new data, including those showing the suggested dosing for these medicines are unlikely to kill or inhibit the virus that causes COVID-19. As a result, we determined that the legal criteria for the EUA are no longer met. Please refer to the Revocation of the EUA Letter and FAQs on the Revocation of the EUA for Hydroxychloroquine Sulfate and Chloroquine Phosphate for more information. [...] Hydroxychloroquine and chloroquine have not been shown to be safe and effective for treating or preventing COVID-19. They are being studied in clinical trials for COVID-19, and we authorized their temporary use during the COVID-19 pandemic for treatment of the virus in hospitalized patients when clinical trials are not available, or participation is not feasible, through an Emergency Use Authorization (EUA). The medicines being used under the hydroxychloroquine/chloroquine EUA are supplied from the Strategic National Stockpile, the national repository of critical medical supplies to be used during public health emergencies. This safety communication reminds physicians and the public of risk information set out in the hydroxychloroquine and chloroquine healthcare provider fact sheets that were required by the EUA.
Claim: The American Medical Association rescinded a previous statement and now says "hydroxychloroquine is okay" for COVID-19. (Rush Limbaugh, 2020-12-15)
Evidence (2020-07-29): "We know that every single good study - and by good study I mean randomised control study in which the data are firm and believable - has shown that hydroxychloroquine is not effective in the treatment of Covid-19," he said. [...] President Trump and his son Donald Trump Jr were among social media users who shared video late on Monday of a group called America's Frontline Doctors advocating hydroxychloroquine as a Covid-19 treatment. [...] Asked about hydroxychloroquine earlier on Tuesday, Dr Fauci said the medication was not an appropriate treatment for Covid-19.